SYNLAB AG new in the Frankfurt Stock Exchange's Prime Standard

Release date: 30 Apr 2021 | Deutsche Börse Cash Market

SYNLAB AG new in the Frankfurt Stock Exchange's Prime Standard

SYNLAB AG (ISIN: DE000A2TSL71) has been listed in the Prime Standard on the Frankfurt Stock Exchange since today. The shares had an initial listing price of €18.00. The issue price was €18.00.

The IPO was accompanied by Goldman Sachs, J.P. Morgan, BofA, Deutsche Bank, Barclays, BNP Paribas, HSBC, Jefferies and UniCredit. Goldman Sachs and J.P. Morgan act as designated sponsors on Xetra. Specialist on the trading venue Börse Frankfurt is Baader Bank.

According to its own statements, SYNLAB AG is the largest European provider of clinical laboratory and medical diagnostic services. With more than 20,000 employees, the company headquartered in Munich operates in 36 countries on four continents. SYNLAB performs approximately 500 million laboratory tests per year and achieved a revenue of €2.6 billion in 2020.

Market Status




Parts of the trading system are currently experiencing technical issues

The trading system is currently experiencing technical issues

Xetra newsboard

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.